Incorporating PHI in decision making: external validation of the Rotterdam risk calculators for detection of prostate cancer-Reference-Cited by-同舟云学术

Incorporating PHI in decision making: external validation of the Rotterdam risk calculators for detection of prostate cancer

Published:2024-03-13 Issue:1 Volume:42 Page:
ISSN:1433-8726
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Rius Bilbao Leire^ORCID,Aguirre Larracoechea Urko,Valladares Gomez Carmen,Remmers Sebastiaan,Mar Medina Carmen, ,Pereira Arias Jose Gregorio,Arredondo Calvo Pablo,Urdaneta Salegui Luis Felipe,Escobal Tamayo Victor,Sanz Jaka Juan Pablo,Recio Ayesa Adrian,Mar Medina Javier

Funder

Berrikuntza + Ikerketa + Osasuna Eusko Fundazioa

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00345-024-04833-5.pdf

Reference28 articles.

1. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660

2. Hugosson J, Roobol MJ, Månsson M et al (2019) A 16-yr follow-up of the european randomized study of screening for prostate cancer. Eur Urol 76(1):43–51. https://doi.org/10.1016/j.eururo.2019.02.009

3. Schröder FH, Hugosson J, Carlsson S et al (2012) Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European randomized study of screening for prostate cancer (ERSPC). Eur Urol 62(5):745–752. https://doi.org/10.1016/j.eururo.2012.05.068

4. Loeb S, Bjurlin MA, Nicholson J et al (2014) Overdiagnosis and overtreatment of prostate cancer. Eur Urol 65(6):1046–1055. https://doi.org/10.1016/j.eururo.2013.12.062

5. Arnsrud Godtman R, Holmberg E, Lilja H, Stranne J, Hugosson J (2015) Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial. Eur Urol 68(3):354–360. https://doi.org/10.1016/j.eururo.2014.12.006